X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiovascular (15) 15
cardiac & cardiovascular systems (13) 13
index medicus (13) 13
humans (11) 11
angioplasty (9) 9
cardiology and cardiovascular medicine (8) 8
male (8) 8
stents (8) 8
aged (7) 7
drug-coated balloon (7) 7
female (7) 7
paclitaxel (7) 7
peripheral artery disease (7) 7
restenosis (7) 7
femoropopliteal artery (6) 6
middle aged (6) 6
treatment outcome (6) 6
amputation (5) 5
coronary angiography (5) 5
lesions (5) 5
time factors (5) 5
drug-eluting balloon (4) 4
internal medicine (4) 4
ischemia (4) 4
mortality (4) 4
patients (4) 4
percutaneous transluminal angioplasty (4) 4
prospective studies (4) 4
abridged index medicus (3) 3
acute coronary syndromes (3) 3
acute myocardial-infarction (3) 3
aged, 80 and over (3) 3
cardiovascular agents - administration & dosage (3) 3
clopidogrel (3) 3
coated materials, biocompatible (3) 3
critical limb ischemia (3) 3
disease (3) 3
equipment design (3) 3
femoral artery (3) 3
femur (3) 3
heart attacks (3) 3
intervention (3) 3
medical imaging (3) 3
myocardial infarction - etiology (3) 3
outcomes (3) 3
paclitaxel - administration & dosage (3) 3
pain (3) 3
percutaneous coronary intervention - methods (3) 3
peripheral arterial disease (3) 3
peripheral vascular disease (3) 3
revascularization (3) 3
stenosis (3) 3
stroke - etiology (3) 3
target lesion revascularization (3) 3
trial (3) 3
acute coronary syndrome - surgery (2) 2
analysis (2) 2
angiography (2) 2
angioplasty, balloon - adverse effects (2) 2
angioplasty, balloon - instrumentation (2) 2
antithrombins - administration & dosage (2) 2
antithrombins - adverse effects (2) 2
artery-disease (2) 2
bleeding (2) 2
cardiac patients (2) 2
cardiology (2) 2
cardiovascular disease (2) 2
chronic total occlusions (2) 2
clinical trials (2) 2
coronary vessels (2) 2
drug-eluting stents (2) 2
electrocardiography (2) 2
europe (2) 2
heparin - administration & dosage (2) 2
heparin - adverse effects (2) 2
hirudins - administration & dosage (2) 2
hirudins - adverse effects (2) 2
implants (2) 2
italy (2) 2
laboratories (2) 2
limb salvage (2) 2
medical colleges (2) 2
medical research (2) 2
medical services (2) 2
medical treatment (2) 2
optical coherence tomography (2) 2
peptide fragments - administration & dosage (2) 2
peptide fragments - adverse effects (2) 2
percutaneous coronary intervention - adverse effects (2) 2
platelet aggregation inhibitors - administration & dosage (2) 2
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (2) 2
popliteal artery - physiopathology (2) 2
prosthesis design (2) 2
randomization (2) 2
randomized-trial (2) 2
recombinant proteins - administration & dosage (2) 2
recombinant proteins - adverse effects (2) 2
registries (2) 2
risk assessment (2) 2
risk factors (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 9, Issue 12, pp. e117 - e120
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 9, Issue 16, pp. 1729 - 1730
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2013, Volume 6, Issue 3, pp. 282 - 289
Objectives This study aimed to appraise 2-year outcomes after percutaneous treatment of femoropopliteal artery disease with paclitaxel-eluting balloons.... 
Cardiovascular | percutaneous transluminal angioplasty | peripheral artery disease | drug-eluting balloon | angioplasty | Peripheral artery disease | Drug-eluting balloon | Percutaneous transluminal angioplasty | Angioplasty
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2017, Volume 10, Issue 7, pp. 728 - 734
Abstract Objectives The aim of this study was to appraise 2-year outcomes after percutaneous transluminal angioplasty of long femoropopliteal artery disease... 
Cardiovascular | drug-eluting balloons | 24 months | long lesions | superficial femoral artery disease
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 9, Issue 9, pp. 950 - 956
Abstract Objectives The aim of this study was to appraise 1-year outcomes after percutaneous treatment of long femoropopliteal artery disease using... 
Cardiovascular | paclitaxel-coated balloon | percutaneous transluminal angioplasty | peripheral artery disease
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 60, Issue 24, pp. 2473 - 2480
Objectives The aim of this study was to evaluate the efficacy of drug-eluting balloons (DEB) compared with paclitaxel-eluting stents (PES) for the reduction of... 
Cardiovascular | Internal Medicine | paclitaxel | restenosis | revascularization | drug-eluting stent | drug-eluting balloon | late loss | Electrocardiography | Cardiology | Electrocardiogram | Stent (Surgery) | Paclitaxel | Heart attacks | Angioplasty | Stents | Coronary vessels
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 15, pp. 1568 - 1576
Abstract Background Drug-eluting balloons (DEB) may reduce infrapopliteal restenosis and reintervention rates versus percutaneous transluminal angioplasty... 
Cardiovascular | Internal Medicine | drug-eluting balloon | peripheral vascular disease | critical limb ischemia | Transluminal angioplasty | Sects | Medical colleges | Ischemia | Stent (Surgery) | Standards | Wound healing | Angioplasty | Laboratories | Mortality | Amputation
Journal Article
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2014, Volume 7, Issue 9, pp. 1057 - 1059
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2014, Volume 7, Issue 3, pp. 305 - 312
Objectives This study sought to evaluate the safety and performance of the Igaki-Tamai (Igaki Medical Planning Company, Kyoto, Japan) biodegradable stent in... 
Cardiovascular | Igaki-Tamai | peripheral artery disease | GAIA study | PLLA stent(s) | biodegradable stent | superficial femoral artery
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2012, Volume 5, Issue 3, pp. 331 - 338
Objectives This study evaluated the use of a paclitaxel-eluting balloon (PEB) for treatment of femoropopliteal arterial disease. Background Conventional... 
Cardiovascular | restenosis | femoropopliteal artery | paclitaxel-eluting balloon(s) | ischemic vascular disease
Journal Article
by Valgimigli, Marco and Frigoli, Enrico and Leonardi, Sergio and Vranckx, Pascal and Rothenbühler, Martina and Tebaldi, Matteo and Varbella, Ferdinando and Calabrò, Paolo and Garducci, Stefano and Rubartelli, Paolo and Briguori, Carlo and Andó, Giuseppe and Ferrario, Maurizio and Limbruno, Ugo and Garbo, Roberto and Sganzerla, Paolo and Russo, Filippo and Nazzaro, Marco and Lupi, Alessandro and Cortese, Bernardo and Ausiello, Arturo and Ierna, Salvatore and Esposito, Giovanni and Ferrante, Giuseppe and Santarelli, Andrea and Sardella, Gennaro and de Cesare, Nicoletta and Tosi, Paolo and van 't Hof, Arnoud and Omerovic, Elmir and Brugaletta, Salvatore and Windecker, Stephan and Heg, Dik and Jüni, Peter and Campo, Gianluca and Uguccioni, Lucia and Tamburino, Corrado and Presbitero, Patrizia and Zavalloni-Parenti, Dennis and Ferrari, Fabio and Ceravolo, Roberto and Tarantino, Fabio and Pasquetto, Giampaolo and Casu, Gavino and Mameli, Stefano and Stochino, Maria Letizia and Mazzarotto, Pietro and Cremonesi, Alberto and Saia, Francesco and Saccone, Giovanni and Abate, Fabio and Picchi, Andrea and Violini, Roberto and Colangelo, Salvatore and Boccuzzi, Giacomo and Guiducci, Vincenzo and Vigna, Carlo and Zingarelli, Antonio and Gagnor, Andrea and Zaro, Tiziana and Tresoldi, Simone and Vandoni, Pietro and Contarini, Marco and Liso, Armando and Dellavalle, Antonio and Curello, Salvatore and Mangiacapra, Fabio and Evola, Rosario and Palmieri, Cataldo and Falcone, Camillo and Liistro, Francesco and Creaco, Manuela and Colombo, Antonio and Chieffo, Alaide and Perkan, Andrea and De Servi, Stefano and Fischetti, Dionigi and Rigattieri, Stefano and Sciahbasi, Alessandro and Pucci, Edoardo and Romagnoli, Enrico and Moretti, Luciano and Moretti, Claudio and De Caterina, Raffaele and Caputo, Marcello and Zimmarino, Marco and Bramucci, Ezio and Di Lorenzo, Emilio and Turturo, Maurizio and Bonmassari, Roberto and Penzo, Carlo and Loi, Bruno and Mauro, Ciro and Petronio, Anna Sonia and Gabrielli, Gabriele and Micari, Antonio and Belloni, Flavia and Amico, Francesco and Comeglio, Marco and Fresco, Claudio and ... and MATRIX Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet, ISSN 0140-6736, 09/2018, Volume 392, Issue 10150, pp. 835 - 848
The Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox (MATRIX) programme was designed to assess the... 
2017 ESC | SITE | ANGIOGRAPHY | METAANALYSIS | MONOTHERAPY | PCI | ACUTE MYOCARDIAL-INFARCTION | INTERVENTION | ARTERY-DISEASE | MEDICINE, GENERAL & INTERNAL | Perioperative Care | Anticoagulants - administration & dosage | Humans | Middle Aged | Heparin - administration & dosage | Male | Antithrombins - administration & dosage | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Acute Coronary Syndrome - complications | Radial Artery | Percutaneous Coronary Intervention - methods | Female | Femoral Artery | Myocardial Infarction - etiology | Mortality | Peptide Fragments - administration & dosage | Acute Coronary Syndrome - diagnostic imaging | Anticoagulants - adverse effects | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Coronary Angiography | Stroke - etiology | Antithrombins - adverse effects | Hirudins - adverse effects | Acute Coronary Syndrome - surgery | Aged | Peptide Fragments - adverse effects | Hemorrhage - chemically induced | Prosthesis Failure - etiology | Stents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Anticoagulants (Medicine) | Coronary heart disease | Analysis | Cardiac patients | Intervention | Myocardial infarction | Short term | Surgical implants | Femur | Heart attacks | Angiography | Medical services | Clinical trials | Antithrombin | Matrix methods | Bleeding | Infusion | Elevation | Randomization | Motivation | Mathematical analysis | Calcium-binding protein | Implants | Cardiology | Thromboembolism | Stents | Cerebral infarction | Stroke | Medical imaging | Coronary artery | Glycoprotein | Glycoproteins | Angina pectoris | Patients | Thrombosis | Troponin | Inhibitors | Clopidogrel | Infarction | Heparin | Acute coronary syndromes | Kardiologi | Cardiac and Cardiovascular Systems
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 6, pp. 838 - 845.e6
Background Transradial intervention (TRI) and bivalirudin infusion compared with transfemoral coronary intervention or unfractionated heparin plus glycoprotein... 
Cardiovascular | BIVALIRUDIN | TRIAL | ANGIOGRAPHY | CARDIAC & CARDIOVASCULAR SYSTEMS | FONDAPARINUX | CLOPIDOGREL | ACUTE MYOCARDIAL-INFARCTION | ACUTE CORONARY SYNDROMES | ST-SEGMENT ELEVATION | PRIMARY PCI | INTERVENTION | Postoperative Hemorrhage - prevention & control | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Heparin - administration & dosage | Male | Antithrombins - administration & dosage | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Percutaneous Coronary Intervention - instrumentation | Percutaneous Coronary Intervention - methods | Platelet Aggregation Inhibitors - administration & dosage | Female | Myocardial Infarction - etiology | Platelet Aggregation Inhibitors - adverse effects | Radial Artery - surgery | Europe | Peptide Fragments - administration & dosage | Treatment Outcome | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Postoperative Hemorrhage - etiology | Stroke - etiology | Antithrombins - adverse effects | Hirudins - adverse effects | Acute Coronary Syndrome - diagnosis | Survival Analysis | Acute Coronary Syndrome - surgery | Aged | Peptide Fragments - adverse effects | Femoral Artery - surgery | Percutaneous Coronary Intervention - adverse effects | Cardiac patients | Glycosaminoglycans | Intervention | Heart attacks | Medical imaging | Mortality | Cardiovascular disease | Clinical outcomes | Molecular weight | Studies | Pain | Ischemia | Coronary vessels | Electrocardiography | Acute coronary syndromes
Journal Article